1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32917659 | Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy. | 2020 Nov | 1 |